Down 50% and Still Standing: 3 Growth Stocks Worth Your Attention Now

The article argues that E.l.f. Beauty, DraftKings, and RH each have meaningful upside after sharp declines, with E.l.f. down more than 50%, DraftKings down nearly 50%, and RH positioning a new RH Estates brand as a future growth driver. E.l.f. could benefit from its Rhode acquisition, DraftKings from margin expansion and potential prediction-market regulation, and RH from luxury expansion and new product initiatives. Overall it is a bullish stock-picking piece rather than a catalyst-driven news event.

Analysis

The common thread is not “cheap growth,” but businesses that can convert brand permission into distribution leverage. ELF’s Rhode deal is the cleaner read-through: if management can keep the brand premium while scaling it through mass-channel machinery, the upside is less about top-line accretion and more about mix expansion and higher shelf productivity. The second-order winner is likely suppliers and creators tied to prestige-adjacent skincare, while the main loser is any mid-tier skincare brand that competes on comparable efficacy claims without celebrity-backed traffic.

DraftKings is facing a more asymmetric regulatory setup than the market is pricing. Prediction markets are a real competitive pressure in the near term, but the bigger issue is whether they become a backdoor for state-level tax arbitrage; if curtailed, DKNG gets a cleaner path to margin expansion. The super-app matters because it increases user frequency and wallet share, but the real catalyst is policy: a favorable ruling or legislation could re-rate the stock faster than incremental revenue growth does.

RH’s opportunity is more niche but potentially more powerful than the market gives it credit for. In luxury home, the winner is the player that can own customization and aspiration simultaneously; if Estates works, RH can move from a showroom story to a recurring design-service ecosystem with better gross margins and stronger pricing power. The risk is that the category remains cyclical longer than management’s rollout cadence, so the stock can stay “too early” for quarters even if the strategy is correct.

Consensus seems to be treating all three as recovery names, but the better framing is option value on platform expansion. The market may be underestimating how much these brands can monetize adjacency once they have the distribution engine or regulatory cover. The main failure mode is execution drag: if acquisition integration, policy uncertainty, or consumer weakness delays the margin inflection, the stocks can remain value traps for 6-12 months despite decent long-term narratives.

Key Decisions for Investors

• Long ELF on a 6-12 month horizon; favor staged entry on weakness rather than chasing momentum. Risk/reward improves if Rhode integration can be validated with channel expansion and mix uplift, with downside limited by the core brand’s existing distribution base.
• Buy DKNG into regulatory volatility, but prefer call spreads or a partial equity position over outright size. Best catalyst window is 3-9 months; upside accelerates if prediction-market restrictions tighten, while downside is policy delay and margin compression from promotional spending.
• Long RH as a 12-month reopening/brand-extension trade, but size modestly because timing risk is high. Use pullbacks to build; the setup is attractive if Estates can prove higher AOV and design-service attachment, but the stock remains vulnerable if housing demand softens further.
• Pair trade: long ELF / short a weaker mid-tier beauty peer with less brand differentiation and less channel leverage. Thesis is that premiumization plus distribution scale will outperform generic “growth-at-any-price” names over the next 2-4 quarters.
• For event-driven accounts, consider DKNG call spreads around legislative or court milestones rather than a cash equity long. The payoff is convex if the legal backdrop improves, while defined risk protects against a prolonged headlines-over-fundamentals tape.